This site is under development. Open QAPonline Open IVFDaily Open IVFCPD Open IVFBenchmark Open IVFLabOnline     Logon Register
Use as part of your new staff development program.

Please contact us if you are interested in contributing to IVFCPD
IVFCPD is undergoing a major consolidation-pages may change frequently.
About
Support
Activities
Certificate


Key Points


Embryo Derieved HYLA2 and implantation+ - Course ID:174 -
Code
SEP271+ [867]
Comment
Access
0 You need to be registered and subscribed to view these activities.
Primary Topic 271
Date
29/3/2021 - [Last Updated:2/4/2021]
Status
3
KeyWords
secretome , implantation ,
Information
Select for more information on Education modules.
Activity Date
Created 29/3/2021
Updated 2/4/2021
Enrolled
Last Visit
Last Activity
Contents
0 Activity ID
7 Key Topics
1 Comments
4 Questions
3 References
0 Activity
0 CPD Minutes

  References All   | Order: Author Year ID

Order
  Code
Title
ID
Enrolled
APACE
187 869      
0
C299 Embryo biosensing by uterine natural killer cells determines endometrial fate at implantation. 869/3235

List of Key Points FILTER: Key Point Background
There are 7 key points collected on this topic but you need to have a current subscription to access them

Notes relating to this Course.
There is 1 note collected on this topic but you need to have a current subscription to access it

Question List
There are 4 questions for subscribers to complete.

References related to Embryo Derieved Hyaluronate/HYLA2 and implantation -[2] [Ref=3]
Kong CS, Ordoņez AA, Turner S, Tremaine T, Muter J, Lucas ES, Salisbury E, Vassena R, Tiscornia G, Fouladi-Nashta AA, Hartshorne G, Brosens JJ, Brighton PJ. Embryo biosensing by uterine natural killer cells determines endometrial fate decisions at implantation. FASEB J. 2021 Apr,35(4):e21336. doi: 10.1096/fj.202002217R ID:3235
Year:2021, DOI:10.1096/fj.202002217R 427 8905 2021 Last edited on 24/3/2021
Marei WF, Salavati M, Fouladi-Nashta AA. Critical role of hyaluronidase-2 during preimplantation embryo development. Mol Hum Reprod. 2013 Sep,19(9):590-9. doi: 10.1093/molehr/gat032 ID:3240
Year:2013, DOI:10.1093/molehr/gat032 0 0 2013 Last edited on 29/3/2021
Adeniyi T, Horne G, Ruane PT, Brison DR, Roberts SA. Clinical efficacy of hyaluronate-containing embryo transfer medium in IVF/ICSI treatment cycles: a cohort study. Hum Reprod Open. 2021 Mar 3,2021(1):hoab004. doi: 10.1093/hropen/hoab004 ID:3244
Year:0, DOI:10.1093/hropen/hoab004 0 8908 0 Last edited on 2/4/2021

Additional References related to Embryo Derieved Hyaluronate/HYLA2 and implantation - [1]

Copyright IVFCPD Pty Ltd
Contact IVFCPD at Office@ivfcpd.com